These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9632304)

  • 1. Accelerated fractionation (AF) in head and neck cancers.
    Jones B; Dale RG
    Radiother Oncol; 1998 Apr; 47(1):107-8. PubMed ID: 9632304
    [No Abstract]   [Full Text] [Related]  

  • 2. Accelerated fractionation (AF) in head and neck cancers.
    Fowler J
    Radiother Oncol; 1998 Apr; 47(1):104-7. PubMed ID: 9632303
    [No Abstract]   [Full Text] [Related]  

  • 3. Accelerated fractionation (AF) in head and neck cancers.
    Esassolak M; Yalman D; Anacak Y; Ozkök S; Haydaroğlu A
    Radiother Oncol; 1998 Apr; 47(1):103-4. PubMed ID: 9632302
    [No Abstract]   [Full Text] [Related]  

  • 4. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
    Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
    Horiot JC; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg AC; Pierart M; Collette L
    Radiother Oncol; 1997 Aug; 44(2):111-21. PubMed ID: 9288839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
    Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
    Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small field radiotherapy of head and neck cancer patients is responsible for oxidatively damaged DNA/oxidative stress on the level of a whole organism.
    Roszkowski K; Gackowski D; Rozalski R; Dziaman T; Siomek A; Guz J; Szpila A; Foksinski M; Olinski R
    Int J Cancer; 2008 Oct; 123(8):1964-7. PubMed ID: 18688851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy oncology: in regard to Fu et al., IJROBP 2000;48:7-16.
    Logie MB
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148. PubMed ID: 11958925
    [No Abstract]   [Full Text] [Related]  

  • 10. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
    Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
    [No Abstract]   [Full Text] [Related]  

  • 11. Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis.
    Matuschek C; Haussmann J; Bölke E; Gripp S; Schuler PJ; Tamaskovics B; Gerber PA; Djiepmo-Njanang FJ; Kammers K; Plettenberg C; Anooshahr B; Orth K; Budach W
    Radiat Oncol; 2018 Oct; 13(1):195. PubMed ID: 30286777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
    Bentzen SM; Saunders MI; Dische S
    Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New advances in high-technology radiotherapy for head and neck cancer.
    Kubicek GJ; Machtay M
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1165-80, viii. PubMed ID: 19010266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirmation of improved local-regional control with altered fractionation in head and neck cancer.
    Fowler JF; Harari PM
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):3-6. PubMed ID: 10924965
    [No Abstract]   [Full Text] [Related]  

  • 16. How the game is played--challenge between therapeutic benefit and acute toxicity in fractionated radiotherapy.
    Maciejewski B; Miszczyk L; Tarnawski R; Składowski K
    Front Radiat Ther Oncol; 2002; 37():174-84. PubMed ID: 11764660
    [No Abstract]   [Full Text] [Related]  

  • 17. In response to Drs. Dubben, Beck-Bornholdt, and Llogie.
    Ang KK; Berkey BA; Pajak TF; Fu KK
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148-50. PubMed ID: 11958923
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.
    Szczesniak MM; Maclean J; Zhang T; Graham PH; Cook IJ
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):697-703. PubMed ID: 25239671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated superfractionated radiotherapy with concomitant boost for locally advanced head-and-neck squamous cell carcinomas.
    Morris MM; Schmidt-Ullrich RK; DiNardo L; Manning MA; Silverman L; Clay L; Johnson CR; Amir C
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):918-28. PubMed ID: 11958884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
    Dobrowsky W; Naudé J
    Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.